Hatchell said Wednesday that Breland finished her five-month course of chemotherapy last week and will have a scan next week that could determine whether she needs additional treatments. However, Hatchell says she is still leaning toward redshirting Breland this year and her return to the lineup would be a "pleasant surprise."

Breland didn't speak to reporters attending the team's preseason media day. She averaged 14 points and 8.5 rebounds per game last year for the Tar Heels, and was a preseason all-Atlantic Coast Conference pick for this year.